Paying cash for prescriptions through President Trump’s new website can save you money.
But not as much as you might think, according to a new study by KFF, a San Francisco-based nonprofit health policy research group, which compared TrumpRx prices to those from pharmacies in Canada, Germany, France and other development countries. For decades, Americans have turned to foreign pharmacies to fill prescriptions because they cost less than at U.S. drugstores.
In February, TrumpRx launched as a digital government-operated portal to offer direct-to-consumer prescriptions with cash prices posted on the website. Drugmakers signed voluntary agreements to sell their drugs on the platform at a lower price, generally in return for tariff exemptions from the administration, according to KFF.
Senate Democrats on Wednesday continued to scuffle with the Trump administration over release of those agreements that were negotiated with more than two dozen pharmaceutical companies as part of Trump’s Most Favored Nation drug initiative, according to the Washington Post. House and Senate Democratic Health Committee leaders first requested release of the agreements in March.
By August 25, the TrumpRx site included 79 brand name drugs from 16 manufacturers, with plans to add more.
The KFF analysis focused on 39 brand-name drugs listed on the website that did not have generic or biosimilar equivalents in the U.S. Of those drugs, 32 had publicly available prices in the peer countries that were used for comparison.
Read More
Results of the price comparison were mixed.
For just over half of the 32 brand-name drugs, the TrumpRx prices were lower than the average listed drug price across the 11 peer countries. The TrumpRx prices were highest for 13 of the drugs among the countries.
For 17 of the 32 drugs, the TrumpRx price was lower than the average price in the other countries; for the other 15 drugs, the TrumpRx price was higher than the average elsewhere.
Among the 15 drugs in the analysis where the TrumpRx price was higher, the price was on average 262% higher than in peer countries. Premarin vaginal cream, which is used to treat menopause symptoms, was over 10 times the price in Canada, which was the only other country where the brand-name drug was available, according to the study.
For nine other drugs, the TrumpRx prices were more than twice the average prices across peer countries, which included Premarin and the Ozempic Pen, $19 versus $237 and $126 versus $349 respectively.
The TrumpRx price for Enbrel, a widely prescribed specialty drug for rheumatoid arthritis, was $3,354 compared to the average price of $641 in the comparable foreign countries.
Among the drugs that cost less through TrumpRx were Aimovig, which is used to prevent migraine headaches: $299 versus $395; Apidra, a fast acting insulin: $35 versus $49; and Duavee, an inhaled medication for lung problems: $30 versus $47.
Kyle McCormick, co-founder of Blueberry Pharmacy in West View, called TrumpRx a “masquerade for GoodRx,” a popular digital price comparison platform.
“For the most part, it’s a new face on GoodRx discount coupons,” he said. “We already knew they were more expensive.”
Three exceptions: Three fertility drugs on the TrumpRx website are offered at significantly lower prices than elsewhere, he said.
Shoppers would be smart to go directly to the drug manufacturer’s website for the best drug prices, where discounts are often available, McCormick said. Printable discount coupons are usually available at the sites.
Aaron Zolbrod, founder of the Health Insurance Store in Forest Hills, was more critical, dismissing TrumpRx as “smoke and mirrors.”
“It’s gaslighting the public,” he said. “The only people who are going to do well are the ones using GLP drugs” because TrumpRx offers them at discounted prices.
For Invokana, for example, a drug that lowers blood sugar for people with Type 2 diabetes, the TrumpRx price of $225 well exceeds the $45 most people with employer-sponsored health insurance would pay, he said.
“It’s not cheaper just because you’re putting it on TrumpRx,” he said. “Nobody with insurance will use it.”





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.